Vir CEO George Scangos, Set To Retire, Reflects On A Long Career In Biotech

 
• By Jessica Merrill
  
Scangos_George_1200x675
George Scangos is retiring as a biotech CEO
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip